Julia Shirvan
Boston, MA Medical Doctor
NPI 1659716082 CMS profile 5701787
55 Fruit St, Boston, MA 02114
General payments
$122,654
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Julia Shirvan of Boston, MA is reported in the CMS Open Payments database as having received $122,654 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $122,654 | 1 |
Beside peers
- Julia Shirvan
- Massachusetts median
- Middle half of Massachusetts
- National median
In program year 2025, general payments to Julia Shirvan were reported at $0. Among 21,560 Massachusetts profiles paid that year, the median was $147 and the middle half received between $45 and $552.
Show as a table
| Year | Julia Shirvan | Massachusetts median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $122,654 | $133 | $40–$617 | $163 |
| 2020 | $0 | $105 | $32–$540 | $114 |
| 2021 | $0 | $124 | $35–$544 | $132 |
| 2022 | $0 | $126 | $40–$510 | $149 |
| 2023 | $0 | $144 | $47–$542 | $160 |
| 2024 | $0 | $144 | $45–$560 | $164 |
| 2025 | $0 | $147 | $45–$552 | $169 |
Breakdown
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.